A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Harald Holte Catherine Thieblemont |
| Publication date | March 24, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |